Foundation for Biomedical Research and Innovation Report issue

Foundation Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2005
NCT00221182
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

cilostazol (pletal) (2 trials)

Drugs in Phase 3 Trials (1)

acetylsalicylic acid (aspirin) (1 trial)

Drugs in Phase 2 Trials (1)

autologous peripheral blood mononuclear cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebrovascular Disorders (Phase 3)

Chest Pain (Phase 2)

Coronary Artery Disease (Phase 2)

Infarction (Phase 2)

Ischemia (Phase 2)

Myocardial Infarction (Phase 2)

Myocardial Ischemia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3